The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination

Veliceasa, D., Hoëpfner, F. T. S., & Volpert, O. V. (2008). PPARγ and Agonists against Cancer: Rational Design of Complementation Treatments. PPAR Research, 2008(), 287-299-128. https://doi.org/10.1155/2008/945275
Wei, B., & Wang, J. (2022). Research Progress in the Application of γ-Polyglutamic Acid. World Scientific Research Journal, 8(5), 7-11. https://doi.org/10.6911/WSRJ.202205_8(5).0002
張凱復（2012）。To investigate the anti-cancer effects of LPPC encapsulating n-Butylidenephthalide in GBM tumor〔碩士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU.2012.00123
Ying, S., Xiao, X., Chen, T., & Lou, J. (2016). PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1. PPAR Research, 2016(), 36-45. https://doi.org/10.1155/2016/2612743
郭盛助（1996）。Chemical Modification of Naturally Occurring Components and Development of New Anticancer Agent。中醫藥雜誌，7(1)，33-34。https://doi.org/10.6940/JCM.199604_7(1).09